BioSpace News Archive

KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60 ® Infusion System With Hizentra ® 50 Ml Prefilled Syringes.

Starton Therapeutics Inc. today entered into a definitive agreement to conduct its Phase 1b trial in multiple myeloma with a global Clinical Research Organization (CRO).

At the EUROMAR Conference 2023 in Scotland, Bruker showcases the latest innovations in magnetic resonance technology for life science and materials science research.

Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio® (inclisiran) to enable earlier use in patients with elevated LDL-C who have an increased risk of heart disease, as an adjunct to diet and statin therapy1.

ABEC, a leader in engineered solutions and services for biotech manufacturing, announced it will deliver multiple Custom Single Run (CSR ® ) single-use systems to Eli Lilly’s next-generation biopharmaceutical manufacturing facility in Limerick, Ireland.

Organogenesis Holdings Inc. today announced that second quarter of fiscal year 2023 financial results will be reported after the market closes on Wednesday, August 9th.

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL), (Incannex, IHL or the Company) is pleased to announce its intention to redomicile from Australia to the United States via proposed schemes of arrangement (Schemes) between Incannex and its shareholders (Share Scheme) and Incannex and its optionholders (Option Scheme).

Sumitomo Pharma America, Inc., as previously announced on April 3, 2023, is pleased to share it has successfully launched its operations in the U.S. and related markets.

NKGen Biotech Inc. today announced that it will have a poster presentation at the upcoming Alzheimer’s Association International Conference (“AAIC”) to be held in Amsterdam, Netherlands and online from July 16–20, 2023.

MBX Biosciences, Inc. today announced the appointment of Steven Prestrelski, Ph.D., M.B.A., as Chief Scientific Officer (CSO).